Women's health test firms to merge:
This article was originally published in Clinica
Executive Summary
Biofield, of Atlanta, Georgia, has signed a letter of understanding for a merger or acquisition with Bay Point Group, which has developed the self-sampling Fournier Feminine Multi-Test for cervical and vaginal diseases. Biofield is developing a noninvasive, radiation-free testing system that it hopes will help distinguish between breast lesions likely to progress to serious disease and those that will not.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.